|
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial |
|
|
|
Titel: |
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial |
Auteur: |
Zhou, Qing Yu, Yan Xing, Ligang Cheng, Ying Wang, Ying Pan, Yueyin Fan, Yun Shi, Jianhua Zhang, Guojun Cui, Jiuwei Zhou, Jianying Song, Yong Zhuang, Wu Ma, Zhiyong Hu, Yanping Li, Gaofeng Dong, Xiaorong Feng, Jifeng Lu, Shun Wu, Jingxun Li, Juan Zhang, Longzhen Wang, Dong Xu, Xinhua Yang, Tsung-Ying Yang, Nong Guo, Yubiao Zhao, Jun Yao, Yu Zhong, Diansheng Xia, Bing Yang, Cheng-Ta Zhu, Bo Sun, Ping Shim, Byoung Yong Chen, Yuan Wang, Zhen Ahn, Myung-Ju Wang, Jie Wu, Yi-Long |
Verschenen in: |
Med |
Paginering: |
Jaargang 6 () nr. 1 pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|